Researchers led by the Francis Crick Institute have found that blocking a particular protein could offer a new way to target leukemic stem cells without causing harm to healthy stem cells.
Jun 23, 2022
0
60
Approximately half of children with neuroblastoma—a childhood cancer that develops from immature nerve cells—have a form that indicates a high likelihood of recurrence. New findings published by Wiley online in Cancer ...
Jun 6, 2022
0
17
A promising avenue of research into chronic lung disease treatment has hit a speed bump, with a new study showing that 3D manufacturing mesenchymal stem cells (MSCs) may not be the panacea hoped for by researchers.
Jun 6, 2022
0
16
Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study led by researchers at Dana-Farber Cancer Institute ...
Jun 5, 2022
0
108
By filtering waste products and toxins from the urine, the kidney is one of the most important players in human metabolism. It is estimated that several million patients worldwide die each year from renal disease. When a ...
Jun 3, 2022
0
3
The immune system remembers. Often this memory, primed by past encounters with threats like bacteria or viruses, is an asset. But when that memory is sparked by internal drivers, like chronic inflammation, it can prove detrimental, ...
Apr 27, 2022
0
274
Cancer researchers at the University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, and at the Medical Faculty of Kiel University have described approaches for improved therapy of adult blood cancer patients in a ...
Apr 21, 2022
0
28
Axicabtagene ciloleucel (axi-cel; Yescarta) was approved for treatment of large B-cell lymphoma (LBCL) that is refractory to first-line chemoimmunotherapy or relapses within a year of first-line chemotherapy, the U.S. Food ...
Apr 15, 2022
0
3
Researchers from The University of Texas MD Anderson Cancer Center showed that natural killer (NK) cells derived from donated umbilical cord blood, combined with a novel bispecific antibody known as AFM13 that targets CD16A ...
Apr 10, 2022
0
61
Almost one third of babies born with hypoplastic left heart syndrome, or HLHS, die from heart failure before their first birthday. By uncovering cellular processes that drive heart failure in these young patients, a new study ...
Apr 7, 2022
0
30
